A Turkish clinical practice study shows that entecavir and tenofovir disoproxil fumarate can effectively maintain long-term virological and biochemical responses in patients with chronic hepatitis B virus infection, both in those with and without cirrhosis.
from The Medical News http://ift.tt/1xlauIK
from The Medical News http://ift.tt/1xlauIK
No comments:
Post a Comment